Aclaris Therapeutics, Inc. (ACRS)
3.49
+0.11
(+3.25%)
USD |
NASDAQ |
Oct 15, 16:00
3.485
0.00 (0.00%)
After-Hours: 20:00
Aclaris Therapeutics Cash from Operations (TTM) : -62.06M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -62.06M |
| March 31, 2026 | -52.20M |
| December 31, 2025 | -47.11M |
| September 30, 2025 | -42.92M |
| June 30, 2025 | -9.988M |
| March 31, 2025 | -12.32M |
| December 31, 2024 | -20.08M |
| September 30, 2024 | -17.90M |
| June 30, 2024 | -64.46M |
| March 31, 2024 | -72.79M |
| December 31, 2023 | -78.32M |
| September 30, 2023 | -90.68M |
| June 30, 2023 | -73.94M |
| March 31, 2023 | -72.95M |
| December 31, 2022 | -67.57M |
| September 30, 2022 | -65.53M |
| June 30, 2022 | -68.32M |
| March 31, 2022 | -60.87M |
| December 31, 2021 | -52.13M |
| September 30, 2021 | -43.92M |
| Date | Value |
|---|---|
| June 30, 2021 | -45.46M |
| March 31, 2021 | -44.06M |
| December 31, 2020 | -38.63M |
| September 30, 2020 | -50.17M |
| June 30, 2020 | -61.38M |
| March 31, 2020 | -71.93M |
| December 31, 2019 | -96.44M |
| September 30, 2019 | -103.30M |
| June 30, 2019 | -109.80M |
| March 31, 2019 | -110.26M |
| December 31, 2018 | -100.81M |
| September 30, 2018 | -91.77M |
| June 30, 2018 | -75.63M |
| March 31, 2018 | -63.88M |
| December 31, 2017 | -54.66M |
| September 30, 2017 | -44.52M |
| June 30, 2017 | -40.72M |
| March 31, 2017 | -40.37M |
| December 31, 2016 | -34.60M |
| September 30, 2016 | -30.67M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Corcept Therapeutics, Inc. | 109.70M |
| Alumis, Inc. | -351.40M |
| ANI Pharmaceuticals, Inc. | 189.47M |
| Veru, Inc. | -26.04M |
| Johnson & Johnson | -- |